Evaluation of propylene glycol methyl ether as a potential challenge agent for leak detection of liquid and headspace from closed system drug transfer devices using Fourier transform infrared spectroscopy-Reference-Cited by-同舟云学术

Evaluation of propylene glycol methyl ether as a potential challenge agent for leak detection of liquid and headspace from closed system drug transfer devices using Fourier transform infrared spectroscopy

Published:2022 Issue:43 Volume:14 Page:4393-4407
ISSN:1759-9660
Container-title:Analytical Methods
language:en
Short-container-title:Anal. Methods

Author:

Westbrook Emily G.¹^ORCID,Doepke Amos²^ORCID,Streicher Robert P.²^ORCID

Affiliation:

1. University of Cincinnati Clermont College, Department of Science & Health, Batavia, OH 45103, USA

2. Chemical and Biological Monitoring Branch, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Cincinnati, OH 45226, USA

Abstract

Choosing an appropriate surrogate of hazardous drugs for use in testing Closed System Drug-Transfer Devices (CSTDs) is a challenging endeavor with many factors that must be considered.

Publisher

Royal Society of Chemistry (RSC)

Subject

General Engineering,General Chemical Engineering,Analytical Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2022/AY/D2AY01128J

Reference23 articles.

1. D. V.Hirst , K. R.Mead , L.Power , E.Kastango , R.Kovein , D.Nue and A.Feng , A Vapor Containment Performance Protocol for Closed System Transfer Devices Used During Pharmacy Compounding and Administration of Hazardous Drugs , NIOSH Docket Number 288, CDC-2015-0075, 2015

2. D. V.Hirst , K. R.Mead , L.Power , E.Kastango , T.Connor , G.DeBord , R. P.Streicher , A.Doepke , D.Neu and A.Feng , A Performance Test Protocol for Closed System Transfer Devices Used During Pharmacy Compounding and Administration of Hazardous Drugs , NIOSH Docket Number 288-A, CDC-2016-0090, 2016

3. Evaluation of three barrier-type closed system transfer devices using the 2015 NIOSH vapor containment performance draft protocol

4. Validation of chemotherapy drug vapor containment of an air cleaning closed-system drug transfer device